Cost-effectiveness of RespiGam at a university teaching hospital.
Veerman
M
M
Reuman
P
P
Burchfield
D
D
Sherman
J
J
D003362:Cost-Benefit Analysis; D005431:Florida; D006776:Hospitals, Pediatric; D006785:Hospitals, University; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000191:economics*; D007223:Infant; D007231:Infant, Newborn; D018357:Respiratory Syncytial Virus Infections / Q000517:prevention & control*; D012136:Respiratory Syncytial Viruses; D012307:Risk Factors
D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous